SUCNR1 regulates insulin secretion and glucose elevates the succinate response in people with prediabetes
- J Clin Invest. 2024 May 7:e173214. doi: 10.1172/JCI173214.
- 1. Unitat de Recerca, Hospital Universitari Joan XXIII, Insitut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.
- 2. Unitat de Recerca, Hospital Universitari Joan XXIII, Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.
- 3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, ELCHE, Spain.
- 4. Departament de Medicina i Cirurgia, Universitat Rovira i Virgili, Reus, Spain.
- 5. Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States of America.
- 6. Institute of Neuroscience, National Research Council, Padova, Italy.
Pancreatic β-cell dysfunction is a key feature of type 2 diabetes, and novel regulators of Insulin secretion are desirable. Here we report that the succinate receptor (SUCNR1) is expressed in β-cells and is up-regulated in hyperglycemic states in mice and humans. We found that succinate acts as a hormone-like metabolite and stimulates Insulin secretion via a SUCNR1-Gq-PKC-dependent mechanism in human β-cells. Mice with β-cell-specific Sucnr1 deficiency exhibit impaired glucose tolerance and Insulin secretion on a high-fat diet, indicating that SUCNR1 is essential for preserving Insulin secretion in diet-induced Insulin resistance. Patients with impaired glucose tolerance show an enhanced nutritional-related succinate response, which correlates with the potentiation of Insulin secretion during intravenous glucose administration. These data demonstrate that the succinate/SUCNR1 axis is activated by high glucose and identify a GPCR-mediated amplifying pathway for Insulin secretion relevant to the hyperinsulinemia of prediabetic states.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Succinate Receptor 1Research Areas: Inflammation/Immunology